- Home
- QURE vs CUZ Comparison
QURE vs CUZ Comparison
Compare QURE & CUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- CUZ
- Stock Information
- Founded
- QURE 1998
- CUZ 1958
- Country
- QURE Netherlands
- CUZ United States
- Employees
- QURE N/A
- CUZ N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- CUZ Real Estate Investment Trusts
- Sector
- QURE Health Care
- CUZ Real Estate
- Exchange
- QURE Nasdaq
- CUZ Nasdaq
- Market Cap
- QURE 4.3B
- CUZ 4.8B
- IPO Year
- QURE 2007
- CUZ N/A
- Fundamental
- Price
- QURE $30.76
- CUZ $25.12
- Analyst Decision
- QURE Strong Buy
- CUZ Buy
- Analyst Count
- QURE 13
- CUZ 11
- Target Price
- QURE $62.33
- CUZ $32.09
- AVG Volume (30 Days)
- QURE 4.6M
- CUZ 1.4M
- Earning Date
- QURE 11-10-2025
- CUZ 10-30-2025
- Dividend Yield
- QURE N/A
- CUZ 5.10%
- EPS Growth
- QURE N/A
- CUZ 3.48
- EPS
- QURE N/A
- CUZ 0.35
- Revenue
- QURE $15,751,000.00
- CUZ $955,949,000.00
- Revenue This Year
- QURE N/A
- CUZ $14.63
- Revenue Next Year
- QURE $229.18
- CUZ $2.97
- P/E Ratio
- QURE N/A
- CUZ $72.38
- Revenue Growth
- QURE N/A
- CUZ 15.46
- 52 Week Low
- QURE $5.50
- CUZ $24.07
- 52 Week High
- QURE $71.50
- CUZ $32.55
- Technical
- Relative Strength Index (RSI)
- QURE 36.57
- CUZ 34.32
- Support Level
- QURE $25.24
- CUZ $25.63
- Resistance Level
- QURE $31.16
- CUZ $26.35
- Average True Range (ATR)
- QURE 3.74
- CUZ 0.64
- MACD
- QURE -2.28
- CUZ 0.03
- Stochastic Oscillator
- QURE 16.43
- CUZ 18.84
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About CUZ Cousins Properties Incorporated
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.